HOME › DRUGS › SUNITINIB
ACTIVE SUBSTANCE / INN

SUNITINIB

Brand name(s): Sunitinib Accord, Sutent
EMA LISTED
AUTHORISED
Gastrointestinal Stromal Tumors;Carcinoma, Renal Cell;Neuroe…
ACTIVE SUBSTANCE
Sunitinib
REGULATORS
EMA
SPONSORS / MAH
Pfizer Limited, Accord Healthcare S.L.U.
TOTAL APPLICATIONS
2
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
Sunitinib AccordAccord Healthcare S.L.U.Authorised11/02/2021Gastrointestinal Stromal Tumors;Carcinoma, Renal Cell;Neuroendocrine Tumors
SutentPfizer LimitedAuthorised19/07/2006Gastrointestinal Stromal Tumors;Carcinoma, Renal Cell;Neuroendocrine Tumors

FULL INTELLIGENCE ON SUNITINIB

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →